MYX — Mayne Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual balance sheet for Mayne Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2021 June 30th	C2022 June 30th	2023 June 30th	C2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	98	96.7	220	149	100
Net Total Accounts Receivable
Net Total Receivables	191	282	210	208	182
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	417	512	554	461	353
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	222	226	51.5	53.3	58.9
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,463	1,288	1,247	1,143	1,015
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	223	629	311	346	261
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	695	742	613	689	644
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	768	546	634	454	370
Total Liabilities & Shareholders' Equity	1,463	1,288	1,247	1,143	1,015
Total Common Shares Outstanding